January 21, 2026 - 00:38

A dynamic panel discussion is set to take place at Park City, focusing on the intersection of filmmaking and technology. Esteemed filmmakers Daniel Kwan, Natasha Lyonne, Noah Segan, and Janet Yang will share their insights on how advancements in technology are influencing the creative process.
The event, organized in collaboration with the Berggruen Institute’s Studio B, promises to be an engaging exploration of the evolving landscape of the film industry. Joining the esteemed panel will be Matt Sivertson from Autodesk, who will delve into the role of emerging tools, particularly artificial intelligence, in transforming creative workflows.
As filmmakers increasingly integrate technology into their storytelling, this discussion aims to illuminate the challenges and opportunities presented by these innovations. Attendees can expect an enlightening dialogue that not only addresses current trends but also envisions the future of filmmaking in an age where technology plays a pivotal role in creativity.
September 30, 2026 - 21:59
Micron Technology Tops Lofty Fiscal Q4 Goals, Guides Above ViewsMicron Technology exceeded analyst expectations for its fiscal fourth quarter, delivering results that outperformed even the most optimistic projections on Wall Street. The memory chip maker...
September 30, 2026 - 01:50
Space Force Turns to Laser Systems to Shield Launch Sites from Drone ThreatsThe U.S. Space Force is moving forward with plans to deploy laser technology as part of a broader effort to defend its launch facilities from unauthorized drones. The initiative focuses on...
September 29, 2026 - 04:58
DIU Seeks Investors in Counter-Unmanned Systems TechnologyThe Defense Innovation Unit is looking for private investors to back companies working on counter unmanned systems technology. The effort targets firms building tools to detect, track, and disable...
September 28, 2026 - 02:02
Novo Nordisk (CPSE:NOVO B) Secures Long-Acting Injectable Technology In €1.165 Billion Nanexa Licensing AgreementNovo Nordisk has entered a global licensing agreement with Swedish drug delivery company Nanexa, valued at up to 1.165 billion euros. The deal centers on Nanexa`s PharmaShell technology, a platform...